文献速递消化、代谢与肾脏急症

氯胺酮作为阿片类药物辅助用于急诊科急性疼痛:一项随机对照试验

Ketamine as an Adjunct to Opioids for Acute Pain in the Emergency Department: A Randomized Controlled Trial.
PubMed 文献 · Acad Emerg Med · 2017-03-22
一句话结论在急诊科中重度疼痛患者中,阿片类药物基础上加用0.1 mg/kg氯胺酮较安慰剂降低120分钟疼痛评分并减少阿片总用量,但头晕/眩晕不良反应更多(51% vs 19%)。

该单中心随机双盲安慰剂对照试验纳入急诊科中重度疼痛且初始阿片剂量后仍高疼痛的患者,比较在方案化追加阿片前给予0.1 mg/kg氯胺酮或安慰剂。结果显示氯胺酮组120分钟内疼痛评分更低(p=0.015),阿片总用量更少(9.95±4.83 mg vs 12.81±6.81 mg,p=0.02),需要追加阿片剂量的患者更少,满意度无差异。氯胺酮组头晕和眩晕报告更多(51% vs 19%),但副作用谱似乎可耐受。

要点

  • 急诊科中重度疼痛且初始阿片剂量后仍高疼痛的患者,在方案化追加阿片前给予0.1 mg/kg氯胺酮,120分钟内疼痛评分低于安慰剂(p=0.015)。
  • 氯胺酮组阿片总用量(含初始剂量)低于安慰剂组:9.95±4.83 mg vs 12.81±6.81 mg(p=0.02)。
  • 氯胺酮组需要追加阿片剂量的患者更少,但两组疼痛控制满意度无差异。
  • 氯胺酮组头晕和眩晕报告更多:51% vs 19%,副作用谱似乎可耐受。

适用人群与场景

  • 急诊科中重度疼痛且初始阿片类镇痛后仍持续高疼痛水平的患者。

处置流程与药物剂量

  • 在初始阿片类镇痛后仍高疼痛的患者中,随机给予0.1 mg/kg氯胺酮或安慰剂,随后按方案需要时追加阿片类镇痛。
  • 评估持续120分钟,包括疼痛水平(0-10)、疼痛控制满意度(0-4)、副作用、镇静水平及额外镇痛药需求。

研究设计与关键结果

  • 单中心随机双盲安慰剂对照试验,纳入急诊科中重度疼痛患者,安慰剂组63例、氯胺酮组53例,两组人口学特征无显著差异。
  • 氯胺酮组120分钟内疼痛评分低于安慰剂组(p=0.015)。
  • 阿片总用量(含初始剂量)氯胺酮组9.95±4.83 mg vs 安慰剂组12.81±6.81 mg(p=0.02),氯胺酮组更低。
  • 疼痛控制满意度两组无差异;氯胺酮组需要追加阿片剂量的患者更少。
  • 氯胺酮组报告头晕和眩晕的患者更多(51% vs 19%),副作用谱似乎可耐受。

证据类型、等级与局限

  • 随机、双盲、安慰剂对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急诊科中重度疼痛且初始阿片剂量后仍高疼痛的患者,在追加阿片前使用0.1 mg/kg氯胺酮可能降低120分钟内疼痛评分并减少阿片总用量和追加次数(作者结论)。
  • 使用氯胺酮时需注意头晕和眩晕不良反应更多(51% vs 19%),但原文认为副作用谱似乎可耐受。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: This study had five objectives: 1) to measure and compare total opioid use and number of opioid doses in patients treated with opioids versus ketamine in conjunction with opioids; 2) to measure pain scores up to 2 hours after presentation in the ED patient with pain, comparing standard opioid pain control to ketamine in conjunction with opioids; 3) to compare patient satisfaction with pain control using opioids alone versus ketamine in conjunction with opioids; 4) to monitor and compare side effects in patients treated with opioids versus ketamine in conjunction with opioids; and 5) to identify effect variation between different subgroups of patients, with the purpose of focusing future research. We hypothesized that low-dose ketamine, compared to placebo, as an adjunctive treatment to opioids would result in better pain control over 2 hours and greater patient satisfaction with pain control; further, this protocol will result in a lower opioid dosage over 2 hours.

METHODS: This was a randomized, double-blinded, placebo-controlled trial at a single academic emergency department evaluating the use of ketamine versus placebo in conjunction with opioids for moderate to severe pain. Subjects with a continued high level of pain after an initial dose of opioid analgesia were randomized to receive either 0.1 mg/kg ketamine or placebo prior to protocol-based dosing of additional opioid analgesia, if required. Over 120 minutes, subjects were assessed for pain level (0-10), satisfaction with pain control (0-4), side effects, sedation level, and need for additional pain medication. Total opioid dose, including the initial dose, was compared between groups.

RESULTS: Sixty-three subjects were randomized to the placebo group and 53 to the ketamine group. No significant differences were found in demographics between the groups. Patients receiving ketamine reported lower pain scores over 120 minutes than patients receiving placebo (p = 0.015). Total opioid dose was lower in the ketamine group (mean ± SD = 9.95 ± 4.83 mg) compared to placebo (mean ± SD = 12.81 ± 6.81 mg; p = 0.02). Satisfaction did not differ between groups. Fewer patients in the ketamine group required additional opioid doses. More patients reported light-headedness and dizziness in the ketamine group.

CONCLUSIONS: Ketamine, as an adjunct to opioid therapy, was more effective at reducing pain over 120 minutes and resulted in a lower total opioid dose as well as fewer repeat doses of analgesia. More side effects were reported in the ketamine group (51% vs. 19%), but the side effect profile appears tolerable.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bowers KJ, McAllister KB, Ray M, et al. Ketamine as an Adjunct to Opioids for Acute Pain in the Emergency Department: A Randomized Controlled Trial. Acad Emerg Med. 2017. PMID: 28177167. doi:10.1111/acem.13172

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。